DFJ — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Dr. Sam Gambhir(Founder)Cyriac Roeding(Co-founder)inDr. David Suhy(Co-founder & Chief Scientific Officer)
BoardJorge Conde(Director)in
Board seatJustin Kao· per SEC Form D · $40M raise · filed Jan 2021
Co-investorsAndreessen HorowitzBreyer CapitalHan River PartnersMenlo VenturesMBX Capital
Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings.
AI & Machine LearningBiotechHealthtechMedical DevicesBurlingame, US
Tim Sweeney(Co-Founder and CEO)Purvesh Khatri(Co-Founder and Chief Scientist)JONATHAN ROMANOWSKY(Executive Officer)
BoardKENNETH BAHK(Director)MICHAEL RUBIN(Director)DAVID PERSING(Director)
Board seatJustin Kao· per SEC Form D · $102.4M raise · filed Mar 2021
Co-investorsKhosla VenturesNorthpond VenturesOSF Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.